By Axel Bugge
LISBON (Reuters) - Europe should heed the threat from opioids
responsible for America's deadliest drug epidemic in decades as both
regions have seen rises in prescription rates of such medicines,
which can be a gateway to dangerous derivatives, experts said.
The U.S. epidemic has led to far more overdose deaths and already
lasted much longer than previous drug crises, like crack cocaine in
the 1980s, and health experts fear it will spread to Europe.
U.S. President Donald Trump was to declare the crisis a public
health emergency on Thursday, senior administration officials said.
Cathy Stannard, a consultant in pain medicine, told the Lisbon
Addictions 2017 conference that the "undoubted public health
disaster of misuse of prescription opioids" in the U.S. had led to
scrutiny of the risks that patients become addicted, or subsequently
turn to heroin.
"We (in Europe) are mindful of all the facets of the U.S.
conversation, but where we start on this is a very similar increase
in prescription rates of opioid medicines."
Christopher Jones, who works at the U.S. Department of Health
researching the opioid addiction, said prescription opioids were
driving the increase in U.S. deaths for many years.
"But we've seen stabilization in that since around 2011. Where we
now see real change is in synthetic opioids," he said.
Drug rings, especially from China, are producing more potent,
dangerous variants of such opioids to hook new users.
[to top of second column] |
Between 2000 and 2015, deaths in the U.S. from synthetic opioids
like fentanyl, a painkiller which is up to 100 times more powerful
than morphine, rose 1,125 percent. In the same period deaths from
all opioids rose 294 percent.
Overall drug overdose deaths in the U.S. reached about 64,000 last
year, up from 52,000 in 2015, Jones said. More than half were
related to opioids.
Europe's overdose deaths rose for the third consecutive year in 2015
to 8,441 and 81 percent of them were related to opioids, which
include heroin.
Europe's Lisbon-based drugs monitoring agency (EMCDDA), which
organized the conference, agreed there was a growing threat from
synthetic opioids.
"We have seen in the last 18 months the rapid emergence of new
highly potent synthetic opioids, mostly fentanyl derivatives," said
EMCDDA scientific director Paul Griffiths. "Their potency means they
pose a significant risk to those that consume them or are
accidentally exposed to them."
Jones said there was a similar trend in the U.S., where new
variations of fentanyl coming from China were cropping up. "There is
a lack of awareness of the drugs people are using, meaning they
can't protect themselves."
(Reporting By Axel Bugge, editing by Andrei Khalip and John
Stonestreet)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|